Correlation Between Candel Therapeutics and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and ZyVersa Therapeutics, you can compare the effects of market volatilities on Candel Therapeutics and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and ZyVersa Therapeutics.
Diversification Opportunities for Candel Therapeutics and ZyVersa Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Candel and ZyVersa is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Candel Therapeutics and ZyVersa Therapeutics
Given the investment horizon of 90 days Candel Therapeutics is expected to generate 0.49 times more return on investment than ZyVersa Therapeutics. However, Candel Therapeutics is 2.04 times less risky than ZyVersa Therapeutics. It trades about -0.07 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 519.00 in Candel Therapeutics on September 5, 2024 and sell it today you would lose (68.00) from holding Candel Therapeutics or give up 13.1% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Candel Therapeutics vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Candel Therapeutics |
| ZyVersa Therapeutics |
Candel Therapeutics and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Candel Therapeutics and ZyVersa Therapeutics
The main advantage of trading using opposite Candel Therapeutics and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |